RBartSangalMD

PubMed

• 7 citations
  The Combination of Aroxybutynin and Atomoxetine in the Treatment of Obstructive Sleep Apnea (MARIPOSA): A Randomized Controlled Trial.
  Paula K Schweitzer, Luigi Taranto-Montemurro, Joseph M Ojile, Russell Rosenberg, Bruce Corser, Brian Abaluck, R Bart Sangal, James Maynard, Drake, C. L., Stephen G The...> ;American Journal of Respiratory and Critical Care Medicine. 2023 Dec 15
• 1 citations
  Efficacy and safety of esmirtazapine in adult insomnia: unsupported statements about residual daytime effects.
  R. Bart Sangal> ;Journal of Clinical Sleep Medicine. 2021 Feb 1
• 1 citations
  Auto-titrating CPAP for the treatment of obstructive sleep apnea in children: APAP and CPAP pressures were not that close
  R Bart Sangal> ;Journal of Clinical Sleep Medicine. 2020 Oct 15
• 5 citations
  Baseline Lighter Sleep and Lower Saturation Are Associated With Improved Sleepiness and Adherence on Continuous Rather Than Autotitrating Positive Airway Pressure
  R. Bart Sangal, Nimish Sudan> ;Clinical EEG and Neuroscience. 2020 May 1
• 1 citations
  Baseline Sleep Efficiency and Arousal Index Do Not Predict Who Will Benefit From Sedatives in Improving Positive Airway Pressure Adherence in Sleep Apnea to 90.
  R. Bart Sangal> ;Clinical EEG and Neuroscience. 2018 Jul 1
• 162 citations
  Suvorexant in Patients With Insomnia: Results From Two 3-Month Randomized Controlled Clinical Trials
  W. Joseph Herring, Kathryn M. Connor, Neely Ivgy-May, Ellen Snyder, Ken Liu, Duane B. Snavely, Andrew D. Krystal, James K. Walsh, Ruth M. Benca, Russell Rosenberg, R. ...> ;Biological Psychiatry. 2016 Jan 15
• 14 citations
  Use of EEG Beta-1 Power and Theta/Beta Ratio Over Broca's Area to confirm Diagnosis of Attention Deficit/Hyperactivity Disorder in Children.
  R. Bart Sangal, JoAnne M. Sangal> ;Clinical EEG and Neuroscience. 2015 Jul 1
• 21 citations
  Eszopiclone for Insomnia Associated With Attention-Deficit/Hyperactivity Disorder
  R. Bart Sangal, Jeffrey L. Blumer, D Alan Lankford, Todd Grinnell, Holly Huang> ;Pediatrics. 2014 Oct 1
• 14 citations
  Evaluating sleepiness-related daytime function by querying wakefulness inability and fatigue: Sleepiness-Wakefulness Inability and Fatigue Test (SWIFT).
  R. Bart Sangal> ;Journal of Clinical Sleep Medicine. 2012 Dec 15
• 7 citations
  Increased central adiposity in morbidly obese patients with obstructive sleep apnoea.
  M. Soriano-Co, Thomas E. Vanhecke, Barry A. Franklin, R. B. Sangal, Basil Hakmeh, Peter A. McCullough> ;Internal Medicine Journal. 2011 Jul 1
• 90 citations
  Subjective and objective measures of sleep in children with attention-deficit/hyperactivity disorder.
  Judith A. Owens, R. Bart Sangal, Virginia K. Sutton, Rosalie J. Bakken, Albert J. Allen, Douglas Kelsey> ;Sleep Medicine. 2009 Apr 1
• 25 citations
  Albuminuria and Renal Function in Obese Adults Evaluated for Obstructive Sleep Apnea
  Varun Agrawal, Thomas E. Vanhecke, Baroon Rai, Barry A. Franklin, R. Bart Sangal, Peter A. McCullough> ;Nephron. Clinical Practice. 2009 Jan 1
• 47 citations
  Cardiorespiratory fitness and obstructive sleep apnea syndrome in morbidly obese patients.
  Thomas E. Vanhecke, Barry A. Franklin, Kerstyn C. Zalesin, R. Bart Sangal, Adam deJong, Varun Agrawal, Peter A. McCullough> ;Chest. 2008 Sep 1
• 23 citations
  Atomoxetine improves sleepiness and global severity of illness but not the respiratory disturbance index in mild to moderate obstructive sleep apnea with sleepiness.
  R. Bart Sangal, JoAnne M. Sangal, Krista Thorp> ;Sleep Medicine. 2008 Jul 1
• 9 citations
  Cardiorespiratory fitness and sleep-related breathing disorders
  Thomas E. Vanhecke, Barry A. Franklin, Steven C. Ajluni, R. Bart Sangal, Peter A. McCullough> ;Expert Review of Cardiovascular Therapy. 2008 Jun 1
• 45 citations
  Effects of atomoxetine on growth in children with attention-deficit/hyperactivity disorder following up to five years of treatment
  Thomas J. Spencer, Christopher J. Kratochvil, R. Bart Sangal, Keith E. Saylor, Charles E. Bailey, David W. Dunn, Daniel A. Geller, Charles D. Casat, Robert S. Lipetz, ...> ;Journal of Child and Adolescent Psychopharmacology. 2007 Nov 3
• 39 citations
  Quality of life assessment in adult patients with attention-deficit/hyperactivity disorder treated with atomoxetine.
  Lenard A. Adler, Virginia K. Sutton, Rodney J. Moore, Anthony Dietrich, Frederick W. Reimherr, R. Bart Sangal, Keith E. Saylor, Kristina Secnik, Douglas Kelsey, Albert...> ;Journal of Clinical Psychopharmacology. 2006 Dec 1
• 135 citations
  Effects of atomoxetine and methylphenidate on sleep in children with ADHD.
  R. Bart Sangal, Judith A. Owens, Albert J. Allen, Virginia K. Sutton, Kory Schuh, Douglas Kelsey> ;Sleep. 2006 Dec 1
• 6 citations
  Attention-deficit/hyperactivity disorder: using P300 topography to choose optimal treatment.
  R. Bart Sangal, JoAnne M. Sangal> ;Expert Review of Neurotherapeutics. 2006 Oct 1
• 23 citations
  Attention-deficit/hyperactivity disorder: use of cognitive evoked potential (P300) to predict treatment response.
  R. Bart Sangal, JoAnne M. Sangal> ;Clinical Neurophysiology. 2006 Sep 1
• 3 citations
  When is sleepiness a disease? How do we measure it?
  R. Bart Sangal> ;Sleep Medicine. 2006 Jun 1
• 58 citations
  A Randomized, Double-Blind, Placebo-Controlled Study of Modafinil Film-Coated Tablets in Children and Adolescents with Attention-Deficit/Hyperactivity Disorder
  Laurence L. Greenhill, Joseph Biederman, Samuel W. Boellner, Thomas Rugino, R. Bart Sangal, Craig Q. Earl, John G. Jiang, James M. Swanson> ;Journal of the American Academy of Child and Adolescent Psychiatry. 2006 May 1
• 46 citations
  Patients with attention-deficit/hyperactivity disorder without observed apneic episodes in sleep or daytime sleepiness have normal sleep on polysomnography.
  R. Bart Sangal, Judith A. Owens, JoAnne M. Sangal> ;Sleep. 2005 Sep 1
• 15 citations
  Attention-deficit/hyperactivity disorder: cognitive evoked potential (P300) amplitude predicts treatment response to atomoxetine.
  R. Bart Sangal, JoAnne M. Sangal> ;Clinical Neurophysiology. 2005 Mar 1
• 188 citations
  The clinical use of the MSLT and MWT.
  Donna L. Arand, Michael H. Bonnet, Thomas D. Hurwitz, Merrill M. Mitler, Roger R. Rosa, R. Bart Sangal> ;Sleep. 2005 Jan 1
• Join now to see all

Journal Articles

• Evaluating Sleepiness-Related Daytime Function by Querying Wake Inability and Fatigue: SWIFT (Sleepiness-Wakefulness Inability and Fatigue Test).  
  Sangal RB., J Clin Sleep Med, 1/1/2012
•  
  Bain EE, Apostol G, Sangal RB, Robieson WZ, McNeill D, Abi-Saab WA, Saltarelli MD., J Clin Psychiatry, 1/1/2012
• Increased central adiposity in morbidly obese patients with Obstructive Sleep Apnea.  
  Soriano-Co M, Vanhecke TE, Franklin BA, Sangal RB, Hakmeh B, McCullough PA., Intern Med J, 1/1/2011
• Subjective and Objective Measures of Sleep in children with Attention-Deficit/Hyperactivity Disorder.  
  Owens J, Sangal RB, Sutton VK, Bakken R, Allen AA, Kelsey D., Sleep Medicine, 1/1/2009
• Albuminuria and Renal Function in Obese Adults Evaluated for Obstructive Sleep Apnea.  
  Agrawal V, Vanhecke TE, Rai B, Franklin BA, Sangal RB, McCullough PA., Nephron Clin Pract, 1/1/2009
• Cardiorespiratory fitness and sleep-related breathing disorders.  
  Vanhecke TE, Franklin BA, Ajluni SC, Sangal RB, McCullough PA., Expert Rev Cardiovasc Ther, 1/1/2008
• Atomoxetine improves Sleepiness and Global Severity of Illness but not the Respiratory Disturbance Index in Mild to Moderate Obstructive Sleep Apnea with Sleepiness.  
  Sangal RB, Sangal JM, Thorp K., Sleep Medicine, 1/1/2008
• Cardiorespiratory Fitness and Obstructive Sleep Apnea Syndrome in Morbidly Obese Patients.  
  Vanhecke TE, Franklin BA, Zalesin KC, Sangal RB, deJong AD, Agrawal V, et al., Chest, 1/1/2008
• Effects of atomoxetine on growth in children with attention-deficit/hyperactivity disorder following up to five years of treatment.  
  Spencer T, Kratochvil C, Sangal RB, Saylor K, Bailey C, Dunn D, Geller D, Casat C, Lipetz R, Jain R, Newcorn J, Ruff D, Feldman P, Furr A, Allen AJ., J Child Adolesc Psychopharmacol, 1/1/2007
• Attention-Deficit/Hyperactivity Disorder: Using P300 Topography to Choose Optimal Treatment.  
  Sangal RB, Sangal JM., Expert Rev Neurother, 1/1/2006
• When is Sleepiness a Disease? How do we Measure It?  
  Sangal RB., Sleep Medicine, 1/1/2006
• A randomized, double-blind, placebo-controlled study of modafinil film-coated tablets in children and adolescents with attention-deficit/hyperactivity disorder.  
  Greenhill LL, Beiderman J, Boellner SW, Rugino TA, Sangal RB, Earl CQ, Jiang JG, Swanson JM., J Am Acad Adolesc Psychiatry, 1/1/2006
• Attention-Deficit/Hyperactivity Disorder: Use of Cognitive Evoked Potential (P300) To Predict Treatment Response.  
  Sangal RB, Sangal JM., Clin Neurophysiology, 1/1/2006
• Quality of life assessment in adult patients with attention-deficit/hyperactivity disorder treated with atomoxetine.  
  Adler LA, Sutton VK, Moore RJ, Dietrich AP, Reimherr FW, Sangal RB, Saylor KE, Secnik K, Kelsey DK, Allen AJ., J Clin Psychopharmacol, 1/1/2006
• Low-Dose Atomoxetine for Maintenance treatment of Attention-Deficit/Hyperactivity Disorder.  
  Newcorn JH, Michelson D, Kratochvil CJ, Allen AJ, Ruff DD, Moore RJ, for the Atomoxetine low-dose study group (incl. Sangal RB)., Pediatrics, 1/1/2006
• Effects of Atomoxetine and Methylphenidate on Sleep in Children With ADHD.  
  Sangal RB, Owens J, Allen AJ, Sutton V, Schuh K, Kelsey D., Sleep, 1/1/2006
• The clinical use of the MSLT and MWT.  
  Arand D, Bonnet M, Hurwitz T, Mitler M, Rosa R, Sangal RB., Sleep, 1/1/2005
• Attention-Deficit/Hyperactivity Disorder: Cognitive Evoked Potential (P300) Amplitude Predicts Treatment Response to Atomoxetine.  
  Sangal JM, Sangal RB., Clin Neurophysiology, 1/1/2005
• Patients With Attention-Deficit/Hyperactivity Disorder Without Observed Apneic Episodes in Sleep or Daytime Sleepiness Have Normal Sleep on Polysomnography.  
  Sangal RB, Owens J, Sangal JM., Sleep, 1/1/2005
• Attention-Deficit/Hyperactivity Disorder: Cognitive Evoked Potential (P300) Topography Predicts Treatment Response to Methylphenidate.  
  Sangal JM, Sangal RB., Clin Neurophysiology, 1/1/2004
• Rating Scales for Inattention and Sleepiness are Correlated in Adults with symptoms of Sleep Disordered Breathing Syndrome, but not in Adults with symptoms of Attentio...  
  Sangal RB, Sangal JM., Sleep Med, 1/1/2004
• Double-Blind, Placebo-Controlled Trial of Dexmethylphenidate Hydrochloride and d,l-threo- Methylphenidate Hydrochloride in children with Attention Deficit Hyperactivit...  
  Wigal S, Swanson JM, Feifel D, Sangal RB, Elia J, Casat CD, Zeldis JB, Conners CK., J Am Acad Child Adolesc Psychiat, 1/1/2004
• A Double-Blind, Placebo-Controlled Withdrawal Trial of Dexmethylphenidate Hydrochloride in Children With Attention Deficit Hyperactivity Disorder.  
  Arnold LE, Lindsay RL, Conners CK, Wigal SB, Levine AJ, Johnson DE, Scott RA, Sangal RB, Bohan TP, Zeldis JB., J Child Adolesc Psychopharm, 1/1/2004
• What is a Significant Response in Drug Studies of Attention Deficit/Hyperactivity Disorder: Statistical Significance is Necessary, but is it Sufficient?  
  Sangal RB, Sangal JM., Psychopharmacology Bulletin, 1/1/2003
• Once-daily atomoxetine treatment for children and adolescents with attention deficit hyperactivity disorder: a randomized, placebo-controlled study.  
  Michelson D, Allen AJ, Busner C, Casat C, Dunn D, Kratochvil C., Newcorn J, Sallee FR, Sangal RB, Saylor K, West S, Kelsey D, Wernicke J, Trapp NJ, Harder D., Am J Psychiatry, 1/1/2002
• Join now to see all

Abstracts/Posters

• A Reliable and Valid Instrument for Measuring Wake Inability and Fatigue: The Sangal Wake Inability and Fatigue Test.
  Sangal RB., Assoc Prof Sleep Societies, Minneapolis, 1/1/2010
• Scale of Wake Ability and Fatigue: A New Scale with High Internal Consistency, Convergent and Discriminant Validity, and Test-Retest Reliability.
  Sangal RB, Stone M., Assoc Prof Sleep Societies, Seattle, WA, 1/1/2009
• Effects of Atomoxetine and Methylphenidate on Sleep in Children with ADHD.
  Sangal RB, Owens J, Allen AJ, Sutton V, Schuh K, Feng MS, Kelsey D., Assoc Prof Sleep Societies, Philadelphia, 1/1/2004
• The Epworth Sleepiness Scale Does Not Measure Perceived Sleepiness in Patients with Sleep Apnea.
  Sangal RB, Sangal JM., Assoc Prof Sleep Societies, Chicago, 1/1/2003
• Patients with Attention Deficit Hyperactivity Disorder Have Normal Sleep on Polysomnography.
  Sangal RB, Sangal JM., Assoc Prof Sleep Societies, Chicago, 1/1/2003
• Polysomnograhic Evidence of Normal Sleep Related Respiration in Patients with Attention Deficit-Hyperactivity Disorder.
  Sangal RB, Sangal JM, Ollila M., Assoc Prof Sleep Societies, Seattle, 1/1/2002
• Rating Scales for Inattention and Sleepiness are correlated in Sleep Disordered Patients, but not in Patients with Attention Deficit-Hyperactivity Disorder.
  Sangal RB, Sangal JM, Ollila M., Assoc Prof Sleep Societies, Chicago, 1/1/2001
• Cognitive Evoked Potentials (P300 Topography) in the Treatment of Attention Deficit.
  Sangal,RB., EEG and Clinical Neuroscience Society, Macon, 1/1/2000
• Patients with Narcolepsy have longer Auditory and Visual P300 Latencies.
  Sangal RB, Sangal JM, Belisle C., Assoc Prof Sleep Societies, New Orleans, 1/1/1998
• P300 Measures in Narcolepsy predict Treatment Response to Modafinil.
  Sangal RB, Sangal,JM, Belisle C., Assoc Prof Sleep Societies, New Orleans, 1/1/1998
• Predicting Treatment Response in Narcolepsy using the P300.
  Sangal,RB, Sangal JM, Belisle C., International Society for Brain Electromagnetic Topography/ EEG and Clinical Neuroscience Society, New Orleans, 1/1/1998
• MWT and ESS Measure Different Abilities in 41 Patients with Snoring and Daytime Sleepiness.
  Sangal RB, Sangal JM, Belisle C., Assoc Prof Sleep Societies, San Francisco, 1/1/1997
• MSLT, MWT and ESS: Indices of Sleepiness in 522 Drug-free Patients with Narcolepsy.
  Sangal RB, Mitler MM, Sangal JM, US Modafinil in Narcolepsy Study Group., Assoc Prof Sleep Societies, San Francisco, 1/1/1997
• Mitler MM, Walsleben J, Sangal RB.
  Mitler MM, Walsleben J, Sangal RB., Assoc Prof Sleep Societies, San Francisco, 1/1/1997
• Computerized Analysis of Abnormal Human Sleep offers Reasonable Results.
  Sangal RB, Semery JP, Belisle C., Assoc Prof Sleep Societies, Washington, 1/1/1996
• P300 Latency: Abnormal in Sleep Apnea with Somnolence and Idiopathic Hypersomnia, but Normal in Narcolepsy.
  Sangal RB, Sangal JM., American Psychiatry Electrophysiology Association, Miami, 1/1/1995
• Closed head injuries, excessive daytime sleepiness, and abnormal visual P300 brain topography.
  Sangal RB, Sangal JM., Assoc Prof Sleep Societies, Boston, 1/1/1994
• P300 brain topography is differentially affected by somnolence of different types.
  Sangal RB, Sangal JM., Assoc Prof Sleep Societies, Boston, 1/1/1994
• Sleep apnea impairs visual cognitive function as measured by P300 brain topography.
  Sangal RB, Sangal JM., Assoc Prof Sleep Societies, Boston, 1/1/1994
• Measures of sleepiness (maintenance of wakefulness test and multiple sleep latency test) and P300 amplitudes and latencies measure different abilities in patients with...
  Sangal RB, Sangal JM., Assoc Prof Sleep Societies, Boston, 1/1/1994
• P300 Topography predicts treatment response in attention deficit disorder.
  Sangal JM, Sangal RB, Persky B., American EEG Society, Chicago, 1/1/1994
• Topography of Auditory and Visual P300 in Normal Adults.
  Sangal RB, Sangal JM., American EEG Society, New Orleans, 1/1/1993
• Topography of Auditory and Visual P300 in Normal Children.
  Sangal JM, Sangal RB., American EEG Society, New Orleans, 1/1/1993
• Severe Daytime Sleepiness causes abnormal Auditory P300 Latency Topography with normal Visual P300 Topography.
  Sangal RB, Sangal JM., American EEG Society, New Orleans, 1/1/1993
• Profound Obstructive Sleep Apnea causes abnormal Visual P300 Latency Topography with normal Auditory P300 Topography.
  Sangal RB, Sangal JM., American EEG Society, New Orleans, 1/1/1993
• Join now to see all

Lectures

• Is ADHD a Sleep Disorder? The Spectrum of Developmental Disabilites 
  Baltimore, MD - 1/1/2007
• Grand Rounds 
  1/1/2007